CVS Settles Insulin Pen Scandal for $38M

CVS Health to Pay $38 Million to Settle Insulin Pen Billing Dispute: The U.S. Attorney in Manhattan announced a settlement where CVS Health agreed to pay nearly $38 million to resolve claims of over-dispensing insulin pens and improperly billing government healthcare programs. The company is accused of dispensing more pens than prescribed, underreporting actual usage, and instructing staff to report maximum days-of-supply for rapid claim approval. The settlement includes $24.45 million for the federal government and funds for various U.S. states. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.